Botulinum Neurotoxin Devoid of Receptor Binding Domain Translocates Active Protease

Overview

Journal PLoS Pathog

Specialty Microbiology

Date 2008 Dec 20

PMID 19096517

Citations 38

Authors

Audrey Fischer

Darren J Mushrush

D Borden Lacy

Mauricio Montal

Affiliations

Soon will be listed here.

Abstract

Clostridium botulinum neurotoxin (BoNT) causes flaccid paralysis by disabling synaptic exocytosis. Intoxication requires the tri-modular protein to undergo conformational changes in response to pH and redox gradients across endosomes, leading to the formation of a protein-conducting channel. The approximately 50 kDa light chain (LC) protease is translocated into the cytosol by the approximately 100 kDa heavy chain (HC), which consists of two modules: the N-terminal translocation domain (TD) and the C-terminal Receptor Binding Domain (RBD). Here we exploited the BoNT modular design to identify the minimal requirements for channel activity and LC translocation in neurons. Using the combined detection of substrate proteolysis and single-channel currents, we showed that a di-modular protein consisting only of LC and TD was sufficient to translocate active protease into the cytosol of target cells. The RBD is dispensable for cell entry, channel activity, or LC translocation; however, it determined a pH threshold for channel formation. These findings indicate that, in addition to its individual functions, each module acts as a chaperone for the others, working in concert to achieve productive intoxication.

Citing Articles

Cryo-EM structure of the botulinum neurotoxin A/SV2B complex and its implications for translocation.

Khanppnavar B, Leka O, Pal S, Korkhov V, Kammerer R Nat Commun. 2025; 16(1):1224.

PMID: 39934119 PMC: 11814414. DOI: 10.1038/s41467-025-56304-z.

Neutralizing chimeric heavy-chain antibody targeting the L-HN domain of Clostridium botulinum neurotoxin type F.

Sun K, Luo S, Jiang Y, Guo J, Wang X, Cheng K Arch Toxicol. 2024; 98(12):4187-4195.

PMID: 39311906 DOI: 10.1007/s00204-024-03869-1.

A Comprehensive Structural Analysis of Neurotoxin A Cell-Binding Domain from Different Subtypes.

Gregory K, Acharya K Toxins (Basel). 2023; 15(2).

PMID: 36828407 PMC: 9966434. DOI: 10.3390/toxins15020092.

Detection of VAMP Proteolysis by Tetanus and Botulinum Neurotoxin Type B In Vivo with a Cleavage-Specific Antibody.

Fabris F, Sostaric P, Matak I, Binz T, Toffan A, Simonato M Int J Mol Sci. 2022; 23(8).

PMID: 35457172 PMC: 9024618. DOI: 10.3390/ijms23084355.

Engineering Botulinum Neurotoxins for Enhanced Therapeutic Applications and Vaccine Development.

Rasetti-Escargueil C, Popoff M Toxins (Basel). 2020; 13(1).

PMID: 33374954 PMC: 7821915. DOI: 10.3390/toxins13010001.

References

Foster K, Adams E, Durose L, Cruttwell C, Marks E, Shone C . Re-engineering the target specificity of Clostridial neurotoxins - a route to novel therapeutics. Neurotox Res. 2006; 9(2-3):101-7. DOI: 10.1007/BF03354881. View

Wang J, Meng J, Lawrence G, Zurawski T, Sasse A, Bodeker M . Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics. J Biol Chem. 2008; 283(25):16993-7002. DOI: 10.1074/jbc.M710442200. View

Nishiki T, Tokuyama Y, Kamata Y, Nemoto Y, Yoshida A, Sekiguchi M . Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA. Neurosci Lett. 1996; 208(2):105-8. DOI: 10.1016/0304-3940(96)12557-x. View

Francis J, Brown Jr R, Figueiredo D, Remington M, Castillo O, Schwarzschild M . Enhancement of diphtheria toxin potency by replacement of the receptor binding domain with tetanus toxin C-fragment: a potential vector for delivering heterologous proteins to neurons. J Neurochem. 2000; 74(6):2528-36. DOI: 10.1046/j.1471-4159.2000.0742528.x. View

Mahrhold S, Rummel A, Bigalke H, Davletov B, Binz T . The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett. 2006; 580(8):2011-4. DOI: 10.1016/j.febslet.2006.02.074. View

Lacy D, Wigelsworth D, Melnyk R, Harrison S, Collier R . Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation. Proc Natl Acad Sci U S A. 2004; 101(36):13147-51. PMC: 516539. DOI: 10.1073/pnas.0405405101. View

Hoch D, Ehrlich B, Finkelstein A, Dasgupta B, Simpson L . Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes. Proc Natl Acad Sci U S A. 1985; 82(6):1692-6. PMC: 397338. DOI: 10.1073/pnas.82.6.1692. View

Montecucco C, Schiavo G, Dasgupta B . Effect of pH on the interaction of botulinum neurotoxins A, B and E with liposomes. Biochem J. 1989; 259(1):47-53. PMC: 1138471. DOI: 10.1042/bj2590047. View

Dong M, Liu H, Tepp W, Johnson E, Janz R, Chapman E . Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Mol Biol Cell. 2008; 19(12):5226-37. PMC: 2592654. DOI: 10.1091/mbc.e08-07-0765. View

10.

Sheridan R . Gating and permeability of ion channels produced by botulinum toxin types A and E in PC12 cell membranes. Toxicon. 1998; 36(5):703-17. DOI: 10.1016/s0041-0101(97)00131-1. View

11.

Fischer A, Montal M . Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes. Proc Natl Acad Sci U S A. 2007; 104(25):10447-52. PMC: 1965533. DOI: 10.1073/pnas.0700046104. View

12.

Duggan M, Quinn C, Chaddock J, Purkiss J, Alexander F, Doward S . Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin. J Biol Chem. 2002; 277(38):34846-52. DOI: 10.1074/jbc.M202902200. View

13.

Trujillo C, Ratts R, Tamayo A, Harrison R, Murphy J . Trojan horse or proton force: finding the right partner(s) for toxin translocation. Neurotox Res. 2006; 9(2-3):63-71. DOI: 10.1007/BF03033924. View

14.

Cai S, Kukreja R, Shoesmith S, Chang T, Singh B . Botulinum neurotoxin light chain refolds at endosomal pH for its translocation. Protein J. 2006; 25(7-8):455-62. DOI: 10.1007/s10930-006-9028-1. View

15.

Jahn R, Lang T, Sudhof T . Membrane fusion. Cell. 2003; 112(4):519-33. DOI: 10.1016/s0092-8674(03)00112-0. View

16.

Schiavo G, Matteoli M, Montecucco C . Neurotoxins affecting neuroexocytosis. Physiol Rev. 2000; 80(2):717-66. DOI: 10.1152/physrev.2000.80.2.717. View

17.

Puhar A, Johnson E, Rossetto O, Montecucco C . Comparison of the pH-induced conformational change of different clostridial neurotoxins. Biochem Biophys Res Commun. 2004; 319(1):66-71. DOI: 10.1016/j.bbrc.2004.04.140. View

18.

Maksymowych A, Simpson L . Structural features of the botulinum neurotoxin molecule that govern binding and transcytosis across polarized human intestinal epithelial cells. J Pharmacol Exp Ther. 2004; 310(2):633-41. DOI: 10.1124/jpet.104.066845. View

19.

Jahn R, Scheller R . SNAREs--engines for membrane fusion. Nat Rev Mol Cell Biol. 2006; 7(9):631-43. DOI: 10.1038/nrm2002. View

20.

Francis J, Hosler B, Brown Jr R, Fishman P . CuZn superoxide dismutase (SOD-1):tetanus toxin fragment C hybrid protein for targeted delivery of SOD-1 to neuronal cells. J Biol Chem. 1995; 270(25):15434-42. DOI: 10.1074/jbc.270.25.15434. View